Pioglitazone, a PPAR-gamma ligand, exerts cytostatic/cytotoxic effects against cancer cells, that do not result from inhibition of proteasome.
Piotr Mrówka(Medical University of Warsaw), Jakub Gołąb(Medical University of Warsaw)
Cited by 7
Related Papers
Myeloid Cell-Derived Arginase in Cancer Immune Response
|Frontiers in Immunology|2020|411
Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
|Nature Communications|2019|309
Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice
|BMC Cancer|2008|74
Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo
|International Journal of Oncology|2007|31